Among patients with chronic obstructive pulmonary disease (COPD) and severe chronic breathlessness, short-term daily treatment with low doses of extended-release morphine did not significantly reduce ...

The BETTER-B clinical trial found that patients with COPD and ILDs using mirtazapine for breathlessness vs placebo had slightly increased adverse events and care use. Among patients with chronic ...

An inexpensive antidepressant proved no better than placebo for alleviating severe, persisting breathlessness from chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD), a ...

Socioeconomic factors, including education and employment status, along with clinical parameters, such as modified Medical Research Council (mMRC) dyspnea scale and Charlson Comorbidity Index (CCI) ...

This new questionnaire could help physicians more easily detect sedentary behaviors among patients with chronic obstructive pulmonary disease (COPD), which standard questionnaires have had difficulty ...